EMD-26739

Single-particle
2.7 Å
EMD-26739 Deposition: 25/04/2022
Map released: 17/08/2022
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-26739

Integrin alphaM/beta2 ectodomain

EMD-26739

Single-particle
2.7 Å
EMD-26739 Deposition: 25/04/2022
Map released: 17/08/2022
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: Integrin alphaM/beta2 ectodomain
Fitted models: 7usm (Avg. Q-score: 0.43)

Deposition Authors: Goldsmith JA , McLellan JS
Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin.
Goldsmith JA , DiVenere AM, Maynard JA, McLellan JS
(2022) Cell Rep , 40 , 111196 - 111196
PUBMED: 35977491
DOI: doi:10.1016/j.celrep.2022.111196
ISSN: 2211-1247
Abstract:
Integrins are ubiquitous cell-surface heterodimers that are exploited by pathogens and toxins, including leukotoxins that target β2 integrins on phagocytes. The Bordetella adenylate cyclase toxin (ACT) uses the αMβ2 integrin as a receptor, but the structural basis for integrin binding and neutralization by antibodies is poorly understood. Here, we use cryoelectron microscopy to determine a 2.7 Å resolution structure of an ACT fragment bound to αMβ2. This structure reveals that ACT interacts with the headpiece and calf-2 of the αM subunit in a non-canonical manner specific to bent, inactive αMβ2. Neutralizing antibody epitopes map to ACT residues involved in αM binding, providing the basis for antibody-mediated attachment inhibition. Furthermore, binding to αMβ2 positions the essential ACT acylation sites, which are conserved among toxins exported by type I secretion systems, at the cell membrane. These findings reveal a structural mechanism for integrin-mediated attachment and explain antibody-mediated neutralization of ACT intoxication.